{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 147,
  "pageCount": 239,
  "prevPage": 146,
  "nextPage": 148,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Uses testimonial quotes to build a narrative of corporate malfeasance and clinical deception.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bullet_list",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/147",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-147",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Although Nevro already bundled low-frequency capability with devices prior to Omnia, KOL's and former employees suggest that the company was paranoid that it would expose its high frequency data as a sham.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b343-967483d068a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.85,
        "x": 0.06,
        "y": 0.21
      },
      "kind": "list",
      "text": "Nevro sales reps who independently activated low-frequency when high frequency failed allegedly faced retaliation from the company.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7c21b0f8-5501-40af-ae80-5ae0f415c66d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.88,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "Although Nevro already bundled low-frequency capability with devices prior to Omnia, KOL’s and former employees suggest that the company was paranoid that it would expose its high frequency data as a sham.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66b7cecb-4d78-4f67-bb5c-510133527ee9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.09,
        "y": 0.63
      },
      "kind": "quote",
      "text": "“Nevro didn’t want the patient to feel paresthesia because what you’ll find is that they crave the paresthesia. Once they feel it, they think that that’s the indication of whether the device is working or not.”",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "799e149a-77b2-4c1c-ba52-d43f60e157f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.09,
        "y": 0.27
      },
      "kind": "quote",
      "text": "“Nevro had a rep in [area redacted] who was reprogramming their devices to use low frequency to try and save failed [high frequency] patients, and Nevro threatened him with an injunction... Nevro was afraid it would disprove their entire clinical trial.”",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b4a6fe38-f49b-48a9-b61c-666429ebb0c0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.09,
        "y": 0.45
      },
      "kind": "quote",
      "text": "“In order to grow the business, some reps would do the paresthesia [low-frequency], and some reps were doing high frequency just like the textbook... the clinical team of Nevro, if they saw that you were doing that, that would be a reduction in your commission percentage.”",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c92234ad-80cf-42b0-bb84-97b10317882c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"Nevro had a rep in [area redacted] who was reprogramming their devices to use low frequency to try and save failed [high frequency] patients, and Nevro threatened him with an injunction. Like, if you tell anybody that it worked we're going to sue you and take away your 401k, Stuff like that. Nevro was afraid it would disprove their entire clinical trial. Several of their reps were doing that.\" — KOL and former high volume Nevro implanter; \"In order to grow the business, some reps would do the paresthesia [low-frequency], and some reps were doing high frequency just like the textbook, and then they wouldn't get cases because the docs were asking them, \"Can you program the patient, so they feel it? Give them both options.\" Well, the clinical team of Nevro, if they saw that you were doing that, that would be a reduction in your commission percentage.\" — Former district manager and part of Nevro's launch team; \"Nevro didn't want the patient to feel paresthesia because what you'll find is that they crave the paresthesia. Once they feel it, they think that that's the indication of whether the device is working or not. You can't just get rid of paresthesia unilaterally and say it's a great thing because there are definitely reasons for it.\" — KOL",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b343-9a5299d1d4f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.06,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2722692b-62e6-474e-8bcb-e37a60621700",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.85,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8aedbc8-e242-4620-a20e-c84aba814930",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "abfa17b1-1746-4e57-a07f-0d2966bdbec1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "expose_contradiction",
      "slug": null,
      "matchId": "41b18648-83af-41e0-9760-25c4cb33dd47",
      "evidence": "The slide contrasts the company's public clinical claims with internal reports of suppressing alternative treatment methods.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}